The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms.
Open Access
- 1 January 1993
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 177 (1), 155-164
- https://doi.org/10.1084/jem.177.1.155
Abstract
F1 hybrid mice are able to acutely reject parental marrow grafts, a phenomenon that is due to natural killer type 1-positive (NK1+) cells. Circumstantial evidence had suggested that the antigenic determinants recognized by these cells are self-antigens, leading to the hypothesis that the physiological role of NK1+ cells is a downregulatory or suppressive function on bone marrow stem cell proliferation and lymphocyte function. In analyzing this hypothesis it is shown here that in young mice there is a temporal correlation between appearance of NK1+ cells in the spleen and the ability to reject allogeneic marrow or to suppress endogenous stem cell proliferation. The reverse situation exists in mice expressing the homozygous lpr gene. Whereas in young mice cells with NK1+ phenotype are demonstrable, these cells disappear with age, i.e., at the time autoimmunity develops. Concomitant with the disappearance of NK1+ cells, the ability to reject marrow grafts and to control endogenous stem cell proliferation also vanishes. The suggestion that the development of autoimmunity is causally related to the disappearance of NK1+ cells is supported by experiments in which NK1+ cells were either eliminated by antibody injection or increased by adoptively transferring cell populations enriched for NK1+ cells into lpr mice. It is shown that removal of cells enhances autoimmunity, whereas injection of NK1+ cells delays the onset of autoimmunity. In vitro assays are presented that demonstrate that suppression of autoantibody-secreting B cells is due to two NK1+ cell populations, one that expresses CD3 and causes specific suppression and one that lacks CD3 and causes nonspecific suppression.Keywords
This publication has 21 references indexed in Scilit:
- Lymphokine-activated killer (LAK) cells: VI. NK1.1+, CD3+ LAK effectors are derived from CD4−, CD8−, NK1.1− precursorsCellular Immunology, 1991
- Expression of Heterozygous lpr Gene in MRL Mice.Scandinavian Journal of Immunology, 1989
- The role of splenic colony-forming units in autoimmune diseaseClinical Immunology and Immunopathology, 1988
- In vivo function of natural killer cells as regulators of myeloid precursor cells in the spleenEuropean Journal of Immunology, 1988
- Expression and function of the CD3-antigen receptor on murine CD4+8+ thymocytesNature, 1987
- Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection.The Journal of Experimental Medicine, 1987
- Detection of native and denatured DNA antibody forming cells by the enzyme‐linked immunospot assay: A clinical study of (New Zealand black × New Zealand white)F1 miceArthritis & Rheumatism, 1986
- Homeostasis of the Antibody Response: Immunoregulation by NK CellsScience, 1983
- Effects of cytotoxic monoclonal antibody specific for T200 glycoprotein on functional lymphoid cell populationsCellular Immunology, 1980
- Mouse lymphocytes with and without surface immunoglobulin: Preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulinJournal of Immunological Methods, 1977